These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15804203)

  • 1. Promoting health and productivity for depressed patients in the workplace.
    Sullivan S
    J Manag Care Pharm; 2005 Apr; 11(3 Suppl):S12-5. PubMed ID: 15804203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression in the workplace: negative effects, perspective on drug costs and benefit solutions.
    Riotto M
    Benefits Q; 2001; 17(2):37-48. PubMed ID: 11372474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving depression treatment by integrated care.
    Rost KM
    J Manag Care Pharm; 2005 Apr; 11(3 Suppl):S5-8. PubMed ID: 15804201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Vicente-Herrero T; Burke TA; Laínez MJ
    Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Productivity losses among treated depressed patients relative to healthy controls.
    Curkendall S; Ruiz KM; Joish V; Mark TL
    J Occup Environ Med; 2010 Feb; 52(2):125-30. PubMed ID: 20134346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Work productivity loss from depression: evidence from an employer survey.
    Rost KM; Meng H; Xu S
    BMC Health Serv Res; 2014 Dec; 14():597. PubMed ID: 25519705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries.
    Evans-Lacko S; Knapp M
    Soc Psychiatry Psychiatr Epidemiol; 2016 Nov; 51(11):1525-1537. PubMed ID: 27667656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.
    Allen D; Hines EW; Pazdernik V; Konecny LT; Breitenbach E
    Hum Resour Health; 2018 Nov; 16(1):59. PubMed ID: 30413168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United States.
    Birnbaum HG; Ben-Hamadi R; Kelley D; Hsieh M; Seal B; Kantor E; Cremieux PY; Greenberg PE
    J Occup Environ Med; 2010 Feb; 52(2):115-24. PubMed ID: 20134337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Productivity loss and productivity loss costs to United States employers due to priority conditions: a systematic review.
    Rojanasarot S; Bhattacharyya SK; Edwards N
    J Med Econ; 2023; 26(1):262-270. PubMed ID: 36695516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hidden costs of employee drinking: A quantitative analysis.
    Sullivan T; Edgar F; McAndrew I
    Drug Alcohol Rev; 2019 Jul; 38(5):543-553. PubMed ID: 31170328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much does quality mental health care profit employers?
    Langlieb AM; Kahn JP
    J Occup Environ Med; 2005 Nov; 47(11):1099-109. PubMed ID: 16282870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective.
    Lamb CE; Ratner PH; Johnson CE; Ambegaonkar AJ; Joshi AV; Day D; Sampson N; Eng B
    Curr Med Res Opin; 2006 Jun; 22(6):1203-10. PubMed ID: 16846553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do antidepressants reduce the burden imposed by depression on employers?
    Greener MJ; Guest JF
    CNS Drugs; 2005; 19(3):253-64. PubMed ID: 15740179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total costs of IBS: employer and managed care perspective.
    Cash B; Sullivan S; Barghout V
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy and productive workers: using intervention mapping to design a workplace health promotion and wellness program to improve presenteeism.
    Ammendolia C; Côté P; Cancelliere C; Cassidy JD; Hartvigsen J; Boyle E; Soklaridis S; Stern P; Amick B
    BMC Public Health; 2016 Nov; 16(1):1190. PubMed ID: 27884132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression management in the workplace: a case study.
    Columbi AM
    J Manag Care Pharm; 2005 Apr; 11(3 Suppl):S16-20. PubMed ID: 15804204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is manager support related to workplace productivity for people with depression: a secondary analysis of a cross-sectional survey from 15 countries.
    Evans-Lacko S; Knapp M
    BMJ Open; 2018 Jul; 8(6):e021795. PubMed ID: 30037899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring productivity outcomes from a brief intervention for at-risk drinking in an employee assistance program.
    Osilla KC; dela Cruz E; Miles JN; Zellmer S; Watkins K; Larimer ME; Marlatt GA
    Addict Behav; 2010 Mar; 35(3):194-200. PubMed ID: 19897312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.